| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/21/2001 | EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/21/2001 | EP1084142A1 Gpr35a receptor |
| 03/21/2001 | EP1084141A1 nrdF |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1083980A2 Modulation of molecular interaction sites on rna and other biomolecules |
| 03/21/2001 | EP1083968A1 FLOW-THROUGH ELECTROPORATION SYSTEM FOR $i(EX VIVO) GENE THERAPY |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1083922A2 Composition and method for treatment of pseudomonas |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083882A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 03/21/2001 | EP1083788A1 Bacteriophage-based transgenic fish for mutation detection |
| 03/21/2001 | EP1053352A4 Mismatch detection techniques |
| 03/21/2001 | EP0865495A4 Progestin-regulated gene |
| 03/21/2001 | EP0842293A4 Peptide library and screening method |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | EP0547201B1 Phagemide for screening antibodies |
| 03/21/2001 | EP0539518B1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 03/21/2001 | CN1288484A Method for processing sucrose into glucose |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288388A Stabilization of lipid DNA formulations during nebulization |
| 03/21/2001 | CN1288062A Method for producing recombination human interleukin 11 using methyl alcohol yeast |
| 03/21/2001 | CN1288061A Method for prepn. of D-pantothenic acid using bar shaped bacteria fermentation |
| 03/21/2001 | CN1288060A Reproduced freely particles in bar shaped bacteria |
| 03/21/2001 | CN1288059A Yeast expression for secretory fusion protein |
| 03/21/2001 | CN1288058A Novel nucleotide series with coded pgi gene |
| 03/21/2001 | CN1288057A Coded novel human angiotensin II-1 receptor related protein gene, and application and prepn. method therefor |
| 03/21/2001 | CN1288056A Novel human coagulation thrombus protein-1 media factor, the application and prepn. method therefor |
| 03/21/2001 | CN1288055A Novel nucleotide series with coded dapF gene |
| 03/21/2001 | CN1063489C Novel polypeptide and DNA coding for the same |
| 03/21/2001 | CN1063488C DNA amplification |
| 03/21/2001 | CN1063483C High-butanol ratio clostridium acetobutylicium and culturing method and use thereof |
| 03/21/2001 | CN1063343C Hepatitis B surface antigen protein having ammonia end with pre-surface antigen determinant |
| 03/20/2001 | US6205404 DNA-binding proteins of the zinc-finger class |
| 03/20/2001 | US6204437 Nucleotide sequences coding regulatory sequences for the control of gene expression in tomato |
| 03/20/2001 | US6204436 Transgenic plants |
| 03/20/2001 | US6204435 Nucleotide sequences which code insect poison; for biological pest control |
| 03/20/2001 | US6204434 Materials and methods for the modification of plant lignin content |
| 03/20/2001 | US6204432 PA28 modified transgenic mice |
| 03/20/2001 | US6204431 Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk |
| 03/20/2001 | US6204377 Kojibiose phosphorylase glucosyl-saccharides produced by transglycosylation |
| 03/20/2001 | US6204375 Preserving ribonucleic acids in cell; incubate cells with blocking agent, the blocker infiltrates the cell and prevents ribonucleic acid degradation in cells |
| 03/20/2001 | US6204373 Plant promoters |
| 03/20/2001 | US6204372 DNA encoding a human tubby homolog |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204252 Granulocytic ehrlichiosis is an acute, potentially fatal tick-borne infection. |
| 03/20/2001 | US6204251 Ocular gene therapy |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204246 Derived from bacillus thuringiensis insecticidal crystal proteins. |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204063 Nucleotide sequences coding mitochondrial polypeptide; for controlling metabolism in plants |
| 03/20/2001 | US6204062 Replacement |
| 03/20/2001 | US6204061 Culturing cells with adjusted nucleotide sequences; transform cells with vector, detect cell with genome adjustment, propagate cells |
| 03/20/2001 | US6204060 Viral vectors and line for gene therapy |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204043 Protease for the treatment of emphysema |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204041 Deregulation of glutamine PRPP amidotransferase activity |
| 03/20/2001 | US6204040 Nucleotide sequence coding oxidoreductase; for use in sorbose fermentation |
| 03/20/2001 | US6204039 Nucleotide sequences coding enzymatic polypeptide; for use in the design and detection of herbicides |
| 03/20/2001 | US6204038 Desaturase antigen of Mycobacterium tuberculosis |
| 03/20/2001 | US6204037 Nucleotide sequences that code enzymatic polypeptide; for monitoring the metabolism of arachidonic acid in preferential cells; and treatment of inflammation and injuries |
| 03/20/2001 | US6204035 Enzymatic protein associated with modulation of coagulation; for preparing tissues, and organs for grafting; anticoauglant; for diagnosis of defective coagulation in humans; for treating autoimmune and inflammatory diseases |
| 03/20/2001 | US6204033 Preparation of polyvinyl alcohol-based magnetic particles for binding biomolecules |
| 03/20/2001 | US6204027 Hammerhead ribozyme of defined rna sequence; has increased catalytic activity without reduction in specificity |
| 03/20/2001 | US6204025 Linking dna segments which are partially complementary to each other and which occur in non-adjacent portions of target dna by using polymerase chain reaction; using several polymerases, one which lacks 3' to 5' exonuclease activity |
| 03/20/2001 | US6204023 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204020 DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof |
| 03/20/2001 | US6204019 Sec A2 from Streptococcus pneumoniae |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204017 Polynucleotide encoding a histamine receptor |
| 03/20/2001 | US6204016 Tyrosylprotein sulfotransferases and methods of use thereof |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204013 Nucleotide sequence of myocardium secreted protein-5; recombinant production; drug screening; therapy of congestive heart failure; probes; primers; antibodies |
| 03/20/2001 | US6204012 Protein production process |
| 03/20/2001 | US6204011 Human receptor tyrosine kinase, KDR |
| 03/20/2001 | US6204010 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/20/2001 | US6204008 Bioprocess for production of dipeptide based compounds |
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203998 Human dopamine receptor and its uses |
| 03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |
| 03/20/2001 | US6203992 Oligonucleotides of defined nucleotide sequence; for use as amplification primers and hybridization probes to detect presence of cytokeratin-19 |
| 03/20/2001 | US6203989 Methods and compositions for amplifying detectable signals in specific binding assays |
| 03/20/2001 | US6203988 DNA fragment preparation method for gene expression profiling |
| 03/20/2001 | US6203986 Visualization of RNA in living cells |